Business
Eli Lilly will get FDA approval for brand spanking new weight problems drug
Business
Here’s what is actually driving tech shares — and it isn’t AI, says Deutsche Bank
Business
Amgen’s inventory hit by expectations its weight problems pipeline is going through an extended wait
Business
Biogen and Eisai launch new Alzheimer’s drug knowledge which will help wider uptake
Business
Why Coke, others, could also be spared, as a $100 billion alternative in weight reduction medication unfolds says JPMorgan
Business
Dialysis firm shares plunge after Ozempic trial success vs. kidney bother
Business
Global dividends hit report $568 billion, however tempo of U.S. payouts slows for sixth straight quarter
Business
Violent clashes are marring a summer time of labor solidarity. Here’s what occurred at a marriage.
Business
The U.S. might not have added any jobs in any respect in July, one Wall Street strategist says
Business
U.S. inventory futures slip after weak China information damps sentiment